510(k) Guidance Footnote May Signal Greater FDA Oversight Of Preclinical Testing
This article was originally published in The Gray Sheet
Executive Summary
Device industry experts say a seemingly minor footnote to the recent 510(k) program draft guidance could create a new requirement for nonclinical studies.
You may also be interested in...
510(k)s Are Subject To Good Laboratory Practice Regs – FDA Draft Guidance
Device manufacturers must declare compliance or explain noncompliance to good laboratory practice regulations for nonclinical studies in all premarket submission types, according to new draft guidance. This has not been the requirement for 510(k)s up until now, says the former CDRH 510(k) policy chief.
510(k)s Are Subject To Good Laboratory Practice Regs – FDA Draft Guidance
Manufacturers must declare compliance or explain noncompliance to good laboratory practice regulations for nonclinical studies in all pre-market submission types, according to a new draft guidance. This has not been the requirement for 510(k)s up until now, says the former CDRH 510(k) policy chief.
Not So Special? FDA Proposal Would Damage Streamlined 510(k) Submissions Program, Firms Say
Agency’s proposed “special 510(k)” reforms, outlined in a recent draft guidance, will make the streamlined submissions program a lot less streamlined, and also less accessible to many device modifications, companies say.